Skip to main content Deutsch

ÖSV Charity: Anna Veith's racing skis as a Christmas present

Buy champion skiers' equipment in an online auction in support of the Center for Precision Medicine from 12 – 19 December
All News
Bild: ÖSV

(Vienna, 12 December 2019) Austria's top skiers and the Dorotheum are supporting MedUni Vienna in the construction of a new research centre for precision medicine, so that currently incurable diseases can be cured in the future. The Dorotheum is auctioning valuable racing equipment from ÖSV ski athletes online between 12 and 19 December 2019 at: Items that are up for auction for this good cause – and just in time for Christmas – include the original racing skis of Olympic gold medallist, 3-times World Champion and twice overall World Cup champion Anna Veith and Katharina Gallhuber's Olympic jacket, in which she won two medals at PyeongChang 2018.

Anna Veith original Head racing skis 2018/19Manuel Feller original racing skis from 2018/19Katharina Gallhuber Olympic jacket from PyeongChang 2018, in which she won two medalsMax Franz original racing suit 2018/19Ricarda Haaser racing suit, worn for several Top 10 placements Stefan Brennsteiner original racing suit 2018/19The items will be available for viewing in the foyer of the Dorotheum in Vienna's first district during the week of the auction. Anyone can take part in the online auction by registering at: The reserve price for each auction item is €50. The proceeds from the auction are going directly towards construction of MedUni Vienna's Center for Precision Medicine (, which is being funded by private donations. The Dorotheum is generously waiving its commission and other auction fees during the auction weeks and will handle all aspects of the online auction.  MedUni Vienna has set up a donations account for those who do not wish to take part in the auction but still want to donate: IBAN: AT46 2011 1404 1007 0714.Precision medicine – medicine of the futurePrecision medicine is based on modern diagnostic techniques, such as genome sequencing and molecular imaging. It will allow patients to be treated in an even more targeted and individual way in the future and will help to identify the cause of the disease at a molecular level.